This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Google Scholar Articles by Mor, P. Articles by Oberle, K. PubMed PubMed Citation Articles by Mor, P. Articles by Oberle, K. Social Bookmarking                   What's this?

Ethical Issues Related To BRCA Gene Testing in Orthodox Jewish Women

University of Calgary, Calgary, Alberta, Canada, pmor{at}012.net.il

Kathleen Oberle

University of Calgary, Calgary, Alberta, Canada

Persons exhibiting mutations in two tumor suppressor genes, BRCA1 and BRCA2, have a greatly increased risk of developing breast and/or ovarian cancer. The incidence of BRCA gene mutation is very high in Ashkenazi Jewish women of European descent, and many issues can arise, particularly for observant Orthodox women, because of their genetic status. Their obligations under the Jewish code of ethics, referred to as Jewish law, with respect to the acceptability of various risk-reducing strategies, may be poorly understood. In this article the moral direction that Jewish law gives to women regarding testing, confidentiality, and other issues is explored. The intent is to broaden nurses' knowledge of how a particular religious tradition could impact on decision making around genetics testing, with the aim of enhancing their understanding of culturally sensitive ethical care.

Key Words: BRCA gene • ethics and genetics • genetics testing • healthy carriers • Jewish ethics • Orthodox Jewish women

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?